(Q38784787)

6 September 2017

Natural History of Nonalcoholic Fatty Liver Disease (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

6 September 2017

1 reference

George Boon-Bee Goh

1

1 reference

PubMed ID

27003142

6 September 2017

Arthur J McCullough

series ordinal

2

1 reference

6 September 2017

22 March 2016

1 reference

Digestive Diseases and Sciences

6 September 2017

1 reference

6 September 2017

61

1 reference

6 September 2017

5

1 reference

6 September 2017

1226-1233

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-016-4095-4

6 September 2017

0 references

cites work

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Clinical features and natural history of nonalcoholic steatosis syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

The global NAFLD epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Prevalence of Nonalcoholic Fatty Liver Disease and Economy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Long term prognosis of fatty liver: risk of chronic liver disease and death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Long-term follow-up of patients with nonalcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Long-term follow-up of patients with NAFLD and elevated liver enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Non-alcoholic fatty liver - perhaps not so benign.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Increased risk of cirrhosis and hepatocellular cancer during long-term follow-up of patients with biopsy-proven NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Long-term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Histological course of nonalcoholic fatty liver disease in Japanese patients: tight glycemic control, rather than weight reduction, ameliorates liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

Progression of liver disease in non-alcoholic fatty liver disease: a prospective clinicopathological follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4095-4

The natural history of nonalcoholic fatty liver: a follow-up study

21 January 2018

1 reference

12 December 2020

Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.

1 reference

12 December 2020

The natural history of nonalcoholic fatty liver disease: a clinical histopathological study

1 reference

12 December 2020

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease

1 reference

12 December 2020

Histological progression of non-alcoholic fatty liver disease in Chinese patients

1 reference

12 December 2020

Economic and Quality-of-Life Implications of Non-Alcoholic Fatty Liver Disease

1 reference

12 December 2020

Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years

1 reference

12 December 2020

Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis

1 reference

12 December 2020

Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies

1 reference

12 December 2020

10.1007/S10620-016-4095-4

Identifiers

DOI

1 reference

PubMed ID

27003142

Dimensions Publication ID

6 September 2017

0 references

1 reference

PubMed ID

27003142